Header Logo

Connection

Philip Liebson to Hypertrophy, Left Ventricular

Back to Details
This is a "connection" page, showing publications Philip Liebson has written about Hypertrophy, Left Ventricular.
Philip Liebson
Connection Strength
1.331
Hypertrophy, Left Ventricular
  1. Optimal antihypertensive therapy for prevention and treatment of left ventricular hypertrophy. Curr Hypertens Rep. 2000 Jun; 2(3):260-70.
    View in: PubMed
    Score: 0.178
  2. Regression of left ventricular hypertrophy. JAMA. 1996 Aug 21; 276(7):526-7.
    View in: PubMed
    Score: 0.137
  3. Is the echocardiogram an appropriate ECG validity standard for the detection and change in left ventricular size? J Electrocardiol. 1996; 29 Suppl:248-55.
    View in: PubMed
    Score: 0.131
  4. Relation between electrocardiography and echocardiography for left ventricular mass in mild systemic hypertension (results from Treatment of Mild Hypertension Study). Am J Cardiol. 1995 Jun 15; 75(17):1233-8.
    View in: PubMed
    Score: 0.126
  5. Clinical correlates and prognostic significance of change in standardized left ventricular mass in a community-based cohort of African Americans. J Am Heart Assoc. 2015 Feb 05; 4(2).
    View in: PubMed
    Score: 0.123
  6. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Circulation. 1995 Feb 01; 91(3):698-706.
    View in: PubMed
    Score: 0.123
  7. Left ventricular mass indexed to height and prevalent MRI cerebrovascular disease in an African American cohort: the Atherosclerotic Risk in Communities study. Stroke. 2005 Mar; 36(3):546-50.
    View in: PubMed
    Score: 0.061
  8. Comparison of the prognostic value of left ventricular hypertrophy in African-American men versus women. Am J Cardiol. 2004 Dec 01; 94(11):1383-90.
    View in: PubMed
    Score: 0.061
  9. Optimal threshold value for left ventricular hypertrophy in blacks: the Atherosclerosis Risk in Communities study. Hypertension. 2005 Jan; 45(1):58-63.
    View in: PubMed
    Score: 0.061
  10. Left ventricular structure and systolic function in African Americans: the Atherosclerosis Risk in Communities (ARIC) study. Ethn Dis. 2004; 14(4):483-8.
    View in: PubMed
    Score: 0.057
  11. Comparison of m-mode echocardiographic left ventricular mass measured using digital and strip chart readings: the Atherosclerosis Risk in Communities (ARIC) study. Cardiovasc Ultrasound. 2003 Jun 27; 1:8.
    View in: PubMed
    Score: 0.055
  12. LIFE and ARBITER. Prev Cardiol. 2003; 6(2):108-11.
    View in: PubMed
    Score: 0.053
  13. Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation. 2001 Aug 14; 104(7):779-82.
    View in: PubMed
    Score: 0.048
  14. Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study. Hypertension. 2000 Jan; 35(1 Pt 1):6-12.
    View in: PubMed
    Score: 0.043
  15. Relations between subclinical disease markers and type 2 diabetes, metabolic syndrome, and incident cardiovascular disease: the Jackson Heart Study. Diabetes Care. 2015 Jun; 38(6):1082-8.
    View in: PubMed
    Score: 0.031
  16. Echocardiography in multicenter clinical trials: experience from the Treatment of Mild Hypertension Study. Control Clin Trials. 1994 Oct; 15(5):395-410.
    View in: PubMed
    Score: 0.030
  17. One-year study of felodipine or placebo for stage 1 isolated systolic hypertension. Hypertension. 2001 Nov; 38(5):1118-23.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.